Obesity is now recognised as a disease that is associated with serious morbidity and
increased mortality. One of its main metabolic complications is type 2 diabetes, as the two …

Nonalcoholic fatty liver disease (NAFLD) is a common, progressive liver disease that affects
up to one-quarter of the adult population worldwide. The clinical and economic burden of …

Background: Bariatric surgery has been shown to significantly reduce cardiovascular risk
factors. However, whether surgery can reduce major adverse cardiovascular events …

Obesity is a significant public health challenge worldwide and is inextricably linked to
adverse cardiovascular outcomes. The relationship between excess adiposity and …

According to the World Health Organization, cardiovascular disease (CVD) remains the
leading cause of death worldwide, accounting for approximately 18 million deaths per year …

Purpose To quantify the impact of bariatric surgery on cardiovascular (CV) risk factors, and
on cardiac structure and function. Data sources Three major databases (PubMed, Medline …

The rising prevalence of obesity, along with high numbers of nonresponders to medical
weight-reduction programs, has led to the evolution and success of bariatric surgery. 1–3 …

Importance There are no approved treatments for nonalcoholic fatty liver disease (NAFLD)
despite its association with obesity and increased risk of cardiovascular disease (CVD) …

Background Short-and mid-term data on Roux-en-Y gastric bypass (RYGB) indicate
sustained weight loss and improvement in co-morbidities. Few long-term studies exist, some …

Background Cohort studies have shown that bariatric surgery may reduce the incidence of
and mortality from cardiovascular disease (CVD), but studies using real-world data are …